Stay updated on Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page.

Latest updates to the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page
- Check3 days agoChange DetectedThe Locations section now lists expanded study sites across the US, Canada, and Europe, and the previous location blocks have been removed.SummaryDifference2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRemoved the Type 1 Diabetes condition label and the MedlinePlus Genetics related topics section from the study page.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded the disease tag Type 1 diabetes and a related topic link to MedlinePlus Genetics on the study page. These additions provide contextual mapping and connect users with related resources.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and the current revision is v3.3.2; the previous PubMed explanation and older revision note (v3.2.0) were removed.SummaryDifference0.0%

- Check38 days agoChange DetectedThe government funding status notice regarding potential data delays and operation status has been removed from the page. Previously, the banner informed users that information may not be up to date.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study’s Locations section was updated to add new sites and remove existing ones across multiple regions, altering the list of participating sites.SummaryDifference0.1%

Stay in the know with updates to Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page.